Primary Care
Novartis is focused on improving the lives of the hundreds of millions of people with hypertension and provides therapies and support programs to treat high blood pressure.
The portfolio includes:
- Amturnide/Rasitrio (aliskiren, amlodipine and hydrochlorothiazide)
- Diovan (valsartan)
- Co-Diovan/Diovan HCT (valsartan with hydrochlorothiazide)
- Exforge (valsartan with amlodipine)
- Exforge HCT (valsartan, amlodipine and hydrochlorothiazide)
- Tekturna/Rasilez (aliskiren)
- Tekturna HCT/Rasilez HCT (aliskiren with hydrochlorothiazide)
- Tekamlo/Rasilamlo (aliskiren and amlodipine)
